LOTTE BIOLOGICS

Company

LOTTE BIOLOGICS is dedicated
to improving the lives of patients worldwide
as a leading global CDMO.

Songdo site

Songdo Site Timeline

Songdo Site Timeline
Overview

Operating a total of three plants in Songdo, Incheon with a capacity of 360,000 liters starting from 2030.

Manufacturing Capabilities

24/7 Multi-product operation for each plant

Production capacity
Stainless Steel Bioreactors 15,000L x8 = 120,000L(Plant 1) Up to 360,000L Drug Substance Manufacturing Capacity
Production capacity
Stainless Steel Bioreactors 3,000L x8(Plant 1) Flexible design considering High-titer Products Drug Substance Manufacturing Capacity
Production capacity
Single-Use Bioreactors Multiple 2,000L(Under Review) Drug Substance Manufacturing Capacity
Production capacity
Drug Product One-Stop Service From Development to Clinical Fill & Finish Drug Product Manufacturing Capabilities
Bioreactor Configuration for Plant 1
Factory 1 bioreactor composition

15,000L Stainless Steel Bioreactors to meet the current market needs for large volume products

Two 3,000L Stainless Steel Bioreactors per train to meet the demand for high-titer product manufacturing

Bio-Venture Initiative

Building facilities for start-ups and venture corporations developing new drugs to encourage collaboration and discovery of new therapeutics.

Lotte Bio-Venture Initiative

Songdo Site Location

418, Songdo-dong, Yeonsu-gu, Incheon, Korea

Syracuse Site (New York, USA)